Is ARE/poly(U)-binding factor 1 (AUF1) a new player in cytokine-mediated beta cell apoptosis?

E C Vanzela1, A K Cardozo

  • 1Faculty of Medicine, Laboratory of Experimental Medicine, Université Libre de Bruxelles, Route de Lennik 808, Building G-E 5th floor, CP 618, 1070 Brussels, Belgium.

Diabetologia
|April 25, 2012
PubMed

Insights

Type 1 diabetes involves beta cell loss due to immune cell cytokines. A new study identifies the RNA-binding protein ARE/poly(U)-binding factor 1 as a key player in cytokine-induced beta cell death, offering therapeutic insights.

Area of Science:

  • Immunology
  • Endocrinology
  • Molecular Biology

Background:

  • Type 1 diabetes is characterized by autoimmune destruction of pancreatic beta cells.
  • Cytokines secreted by immune cells trigger beta cell apoptosis, contributing to disease progression.
  • Understanding cytokine signaling pathways in beta cells is crucial for developing new therapies.

Purpose of the Study:

  • To investigate the molecular mechanisms underlying cytokine-induced beta cell apoptosis.
  • To identify novel regulatory factors involved in beta cell death pathways.
  • To explore the role of the RNA-binding protein ARE/poly(U)-binding factor 1 in this process.

Main Methods:

  • Analysis of signal transduction pathways activated by cytokines in beta cells.
  • Investigation of the involvement of transcription factors like NFκB and JNK.
  • Examination of endoplasmic reticulum (ER) stress and mitochondrial apoptotic pathways.
  • Identification and characterization of the RNA-binding protein ARE/poly(U)-binding factor 1.

Main Results:

  • Cytokine-mediated beta cell apoptosis involves activation of NFκB, JNK, ER stress, and mitochondrial pathways.
  • NFκB contributes to beta cell apoptosis, partly through ER stress induction.
  • The RNA-binding protein ARE/poly(U)-binding factor 1 emerges as a significant factor in these apoptotic responses.
  • ER stress activation involves C/EBP homologous protein and the mitochondrial pathway.

Conclusions:

  • ARE/poly(U)-binding factor 1 is a newly identified player in cytokine-induced beta cell apoptosis.
  • These findings provide new targets for therapeutic interventions aimed at preserving beta cell mass in Type 1 diabetes.
  • Further research into this RNA-binding protein could lead to novel strategies for Type 1 diabetes treatment.

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
Caspases01:24

Caspases

Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside cells.
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.